LS: Today I have the pleasure of interviewing Dr. Jorge Miranda Massari. Dr Massari is a clinical pharmacist and researcher. His research focuses on pharmacologic nutritional biochemistry and metabolic optimization in cancer, diabetes, and autism. Dr Massari, do you work with patients directly? JMM: I work directly with patients in…
In a situation where a patient is doing watchful waiting, why not enhance their watchful period with optimizing their diet and nutrition, and potentially reducing their likelihood of having the cancer progress? In that situation the only side effects of proper dietary changes are good ones, such as reducing the likelihood of comorbidities like diabetes, obesity, or heart disease.
Our endogenous cannabinoid system probably helps modulate our response to pain. The largest evidence base for this in the literature is for neuropathic pain, not necessarily chemo-induced neuropathy, but HIV neuropathy and even a small study in diabetic neuropathy. In animal models, laboratory cannabinoids seem to not only treat but also prevent chemotherapy-induced neuropathy caused by the vinca alkaloids, taxanes, and platinums, which are the three main classes of chemotherapy agents. In addition, insomnia seems to be something that both THC and CBD may be able to address.
My experience has been that most patients take to fasting very well, and they often want to do more than I want them to do. Fasting becomes, for most people, much easier the more they do it. Once you've up-regulated the enzymes that allow you to tap into your fat reserves for fuel, it becomes easier. The first couple of days are the hardest, especially for someone new to fasting. For people who are on a vegetarian diet, or another type of diet very high in carbohydrates, it will be harder to get into ketosis, which is when the engines of fasting rev up and you start feeling a little bit better. But people who have been on a ketogenic diet or who are experienced fasters will be able to metabolize fat pretty easily, and will slip into the fasting mode quite quickly.
Liz Sutherland, ND, editor-in-chief of the Journal of Restorative Medicine had the pleasure of interviewing Kent Holtorf, MD, who will be presenting at the 2019 Restorative Medicine Conference in San Diego LS: Dr. Holtorf, please share some information with us about your background. KH: I went to Berkeley and then UCLA…
